| 臺大學術典藏 |
2021-09-01T01:54:08Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma
|
Lu Y.-S.; Chou C.-H.; Tzen K.-Y.; Gao M.; ANN-LII CHENG; Kulp S.K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:28Z |
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
|
Liu W.-L.; Gao M.; Tzen K.-Y.; Tsai C.-L.; Hsu F.-M.; ANN-LII CHENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:21Z |
Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer
|
Chen Y.-H.; Wei M.-F.; Wang C.-W.; Lee H.-W.; Pan S.-L.; Gao M.; Kuo S.-H.; ANN-LII CHENG; Teng C.-M. |
| 臺大學術典藏 |
2021-07-03T03:35:33Z |
Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy
|
Hsu C.-H.; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-21T07:17:48Z |
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
|
Liu W.-L.; Gao M.; Tzen K.-Y.; CHIAO-LING TSAI; Hsu F.-M.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-04-28T06:58:21Z |
Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer
|
Chen Y.-H.; Wei M.-F.; CHUN-WEI WANG; Lee H.-W.; Pan S.-L.; Gao M.; Kuo S.-H.; Cheng A.-L.; Teng C.-M. |
| 臺大學術典藏 |
2021-03-18T05:59:08Z |
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma
|
Lu Y.-S.; Chou C.-H.; KAI-YUAN TZEN; Gao M.; Cheng A.-L.; Kulp S.K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T05:59:03Z |
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
|
Liu W.-L.; Gao M.; KAI-YUAN TZEN; Tsai C.-L.; Hsu F.-M.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-10T02:36:30Z |
A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer
|
YEN-SHEN LU; Lee K.S.; Chao T.-Y.; Tseng L.-M.; Chitapanarux I.; Chen S.-C.; Liu C.-T.; Sohn J.; Kim J.H.; Chang Y.-C.; Yang Y.; Shotelersuk K.; Jung K.H.; Valenti R.; Slader C.; Gao M.; Park Y.H. |
| 臺大學術典藏 |
2021-03-04T07:51:45Z |
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion
|
Yu, Y.-R.;Imrichova, H.;Wang, H.;Chao, T.;Xiao, Z.;Gao, M.;Rincon-Restrepo, M.;Franco, F.;Genolet, R.;Cheng, W.-C.;Jandus, C.;Coukos, G.;Jiang, Y.-F.;Locasale, J.W.;Zippelius, A.;Liu, P.-S.;Tang, L.;Bock, C.;Vannini, N.;Ho, P.-C.; Yu, Y.-R.; Imrichova, H.; Wang, H.; Chao, T.; Xiao, Z.; Gao, M.; Rincon-Restrepo, M.; Franco, F.; Genolet, R.; Cheng, W.-C.; Jandus, C.; Coukos, G.; Jiang, Y.-F.; Locasale, J.W.; Zippelius, A.; Liu, P.-S.; Tang, L.; Bock, C.; Vannini, N.; Ho, P.-C.; YI-FAN JIANG |
| 臺大學術典藏 |
2021-02-23T08:26:41Z |
A pathway for tumor necrosis factor-�\-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-�eB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus
|
Pei Y.Y.; SUNG-HSIN KUO; Yeh K.-H.; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:33Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Sung-Hsin Kuo;Hsu C.-H.;Chen L.-T.;Lu Y.-S.;Lin C.-H.;Yeh P.-Y.;Jeng H.-J.;Gao M.;Yeh K.-H.;Cheng A.-L.; SUNG-HSIN KUO; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:33Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Sung-Hsin Kuo;Hsu C.-H.;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO; Hsu C.-H.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:25Z |
Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer
|
Chen Y.-H.;Wei M.-F.;Wang C.-W.;Lee H.-W.;Pan S.-L.;Gao M.;Sung-Hsin Kuo;Cheng A.-L.;Teng C.-M.; Chen Y.-H.; Wei M.-F.; Wang C.-W.; Lee H.-W.; Pan S.-L.; Gao M.; SUNG-HSIN KUO; Cheng A.-L.; Teng C.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:47Z |
A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus
|
Pei Y.Y.;Kuo S.-H.;Kun-Huei Yeh;Chuang S.-E.;Hsu C.-H.;Wen C.C.;Lin H.-I.;Gao M.;Cheng A.-L.; Pei Y.Y.; Kuo S.-H.; KUN-HUEI YEH; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:42Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H.;Hsu C.-H.;Chen L.-T.;Lu Y.-S.;Lin C.-H.;Yeh P.-Y.;Jeng H.-J.;Gao M.;Kun-Huei Yeh;Cheng A.-L.; Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2020-12-18T07:11:30Z |
Electron-electron interactions in the two-dimensional semiconductor InSe
|
FANG-CHENG CHOU; Gao, X.P.A.; Chou, F.-C.; Sankar, R.; Kumar, U.R.; Gao, M.; Premasiri, K.; Kumar, A.S. |
| 國家衛生研究院 |
2020-10-05 |
Disturbed mitochondrial dynamics in CD8(+)TILs reinforce T cell exhaustion
|
Yu, YR;Imrichova, H;Wang, HP;Chao, T;Xiao, ZT;Gao, M;Rincon-Restrepo, M;Franco, F;Genolet, R;Cheng, WC;Jandus, C;Coukos, G;Jiang, YF;Locasale, JW;Zippelius, A;Liu, PS;Tang, L;Bock, C;Vannini, N;Ho, PC |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-�eB (NF-�eB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
|
Cheng A.-L.;Gao M;Liao C.-M;Lai G.-M;Yen-Shen Lu;Yeh P.-Y;Chuang S.-E; Chuang S.-E; Yeh P.-Y; YEN-SHEN LU; Lai G.-M; Liao C.-M; Gao M; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-�eB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
|
Yen-Shen Lu;Yeh P.-Y;Chuang S.-E;Gao M;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Yeh P.-Y; Chuang S.-E; Gao M; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:05Z |
NF-�eB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells
|
Cheng A.-L.;Kuo M.-L;Chang W.C;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Chang W.C; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma
|
Cheng A.-L.;Kuo M.-L;Chen C.-S;Feng W.-C;Lee W.-C;Chen K.-F;Hsu C.-H;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Hsu C.-H; Chen K.-F; Lee W.-C; Feng W.-C; Chen C.-S; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:01Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H;Hsu C.-H;Chen L.-T;Yen-Shen Lu;Lin C.-H;Yeh P.-Y;Jeng H.-J;Gao M;Yeh K.-H;Cheng A.-L.; Kuo S.-H; Hsu C.-H; Chen L.-T; YEN-SHEN LU; Lin C.-H; Yeh P.-Y; Jeng H.-J; Gao M; Yeh K.-H; Cheng A.-L. |
